Skip to content
  • Newsroom
    • Eye on Employee Benefits Blog
    • ERIC in the News
    • Media Contact Info
    • Staff Bios
  • My Account
  • Contact Us
  • About ERIC
    • How ERIC Is Different From Other Trade Groups
    • ERIC’s Board of Directors
    • Employee Benefit Job Postings
    • ERIC’s Advisory Council
    • Member Directory
    • Policy Priorities
    • Celebrating 50 Years of Service
  • Health Care
    • Federal
    • State & Local
    • Biosimilars: Cost Savings & Competition
    • E-Delivery for Health & Welfare Plans
    • Solutions for Mental Health – Addressing Mental Health Disparity
  • Retirement & Compensation
    • Federal
    • State & Local
    • Employers & State Paid Leave Patchwork
  • Paid Leave & State Mandates
    • Paid Leave
    • State Health Reform Efforts
    • Biosimilars
    • State Retirement Plans
    • Telehealth
    • State Resources
  • Advocacy & Litigation
    • Protecting ERISA Preemption
    • ERIC Legal Center
    • Litigation
    • Amicus Briefs
    • Letters to Lawmakers
    • Letters to Agencies
    • Testimony
    • Surveys
    • ERIC Wins
  • Events & Meetings
    • Calendar of Events
    • Webinar Library
    • Policy Conferences
    • Sponsor an Event
  • Newsroom
    • Eye on Employee Benefits Blog
    • ERIC in the News
    • Media Contact Info
    • Staff Bios
  • My Account
  • Contact Us

Category Archives: Prescription Drugs

Victory! Chair Wyden Prescription Drug Proposal, Employers on Aduhelm, ACA Reporting Comments & RFI on Prescription Drug Costs

Sorry, but you do not have permission to view this content.

ACA Decision, No Surprises Act Update, HHS Budget Hearings & President Biden’s Regulatory Agenda

Sorry, but you do not have permission to view this content.

Implementing “No Surprises Act”, “Telehealth Expansion Act” Support, Colorado Employer Buying Power & FTC Prescription Drug Report

Sorry, but you do not have permission to view this content.

President’s Budget, EEOC Guidance on Vaccine Incentives & Prescription Drug Research

Sorry, but you do not have permission to view this content.

Public Option RFI, Prescription Drug Update & Surprise Medical Billing Regulation Frustration

Sorry, but you do not have permission to view this content.

Telehealth Expansion Act Reintroduced, Prescription Drugs and Price Transparency Bills & COBRA Guidance

Sorry, but you do not have permission to view this content.

Prescription Drug Hearings, HSA and Telehealth Bills, Employer Hospital Letter & HHS Budget Hearing

Sorry, but you do not have permission to view this content.

House and Senate Hearings This Week, American Families Plan, Price Transparency & MA Plans

Sorry, but you do not have permission to view this content.

Tri-Agency Letter, Ways and Means Telehealth Hearing, House Rx Legislation Introduced, EBSA COBRA Compliance Webcast & EEOC Hearing

Sorry, but you do not have permission to view this content.

ERIC Testifies on Mental Health, E&C Hearing on Substance Abuse, Vaccine Incentive Letter& President Biden’s 2022 Budget

Sorry, but you do not have permission to view this content.

Posts pagination

Newer posts 1 … 13 14 15 16 17 … 28 Older posts
  • Newsroom
  • My Account
  • Contact Us
  • Privacy Policy
1032 15th St. NW, Suite 390, Washington, DC 20005-1503 | Phone: (202) 789-1400 | Fax: (202) 789-1120
© 2026 The ERISA Industry Committee. All Rights Reserved.

Web Design & Development by Matrix Group International, Inc